Molecular Mechanisms in Reproductive Cancers
Submission Deadline: 31 Dec 2025
Guest Editor

Department of Experimental and Clinical Medicine, Faculty of Medicine and Surgery, Polytechnic University of Marche, Ancona, Italy
Interests: gynaecologic cancers; pregnancy complications; natural; synthetic, compounds; urogenital cancers; oxidative stress
Special Issue in IMR Press journals
Special Issue in Pathophysiology of Placenta
Special Issue Information
Dear Colleagues,
We are pleased to invite you to submit a manuscript to the Special Issue “Molecular Mechanisms in Reproductive Cancers”. Despite significant progress in tumor therapy over the past few decades, the development of chemoresistance and metastatic disease is still the most common cause of death in patients with reproductive cancer. These include cervical, ovarian, endometrial, vaginal, vulvar, breast, testicular, penile, and prostate cancers.
The development of new therapeutic approaches that can improve the diagnosis and treatment of these patients are therefore urgently required. A better understanding of the molecular changes in reproductive cancers should lead to the identification of useful molecular biomarkers that can accurately predict tumor outcome and the development of chemoresistance and metastasis.
For this Special Issue, we welcome original research articles and reviews, as well as communications, mini-reviews, systematic reviews and meta-analyses related to reproductive cancers.
We look forward to receiving your contributions.
Dr. Giovanni Tossetta
Guest Editor
Keywords
- cervical
- ovarian
- endometrial
- breast
- testicular
- prostate
- cancer
- reproductive cancers
Published Paper (1)
Excavation of Molecular Subtypes of Cervical Cancer Based on DNA Methylation Patterns
Front. Biosci. (Landmark Ed) 2025, 30(9), 45025; https://doi.org/10.31083/FBL45025
(This article belongs to the Special Issue Molecular Mechanisms in Reproductive Cancers)
